| NKT cells can directly mediate lysis of infected and cancer cells, as well as induce other effector cells through their expeditious release of cytokines. |
| Adoptive transfer of NKT cells into cancer patients holds promise as NKT cells can target these cells and mediate protection. |
| Current immunotherapeutic strategies using chimeric antigen receptors, bispecific T cell engagers, and tumor vaccines are being developed to harness the potential of NKT cells. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.